Sage, Andrew T. http://orcid.org/0000-0003-2517-9062
Donahoe, Laura L.
Shamandy, Alaa A.
Mousavi, S. Hossein http://orcid.org/0000-0002-4891-3138
Chao, Bonnie T.
Zhou, Xuanzi
Valero, Jerome
Balachandran, Sharaniyaa
Ali, Aadil
Martinu, Tereza
Tomlinson, George
Del Sorbo, Lorenzo
Yeung, Jonathan C. http://orcid.org/0000-0001-5759-3028
Liu, Mingyao
Cypel, Marcelo http://orcid.org/0000-0001-5652-1938
Wang, Bo
Keshavjee, Shaf http://orcid.org/0000-0003-4547-8094
Funding for this research was provided by:
Mitacs (#FR42063)
Canada Foundation for Innovation (#33348)
Genome Canada and Ontario Genomics
Article History
Received: 28 September 2022
Accepted: 26 July 2023
First Online: 9 August 2023
Competing interests
: S.K. serves as Chief Medical Officer of Traferox Technologies and receives personal fees from Lung Bioengineering, outside the submitted work. A.T.S., J.V., M.L., M.C., B.W., and S.K. are inventors of patents related to the submitted work. The inventors fully adhere to policies at University Health Network that ensure academic integrity and management of potential conflicts of interest. The remaining authors declare no competing interests.